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Targeted disruption of the tyrosine phosphatase PTPα leads to
constitutive downregulation of the kinases Src and Fyn
Sathivel Ponniah*†, Dennis Z.M. Wang*‡, Kah Leong Lim*‡ and Catherine J. Pallen*
A role for the receptor-like protein tyrosine phosphatase
α (PTPα) in regulating the kinase activity of Src family
members has been proposed because ectopic
expression of PTPα enhances the dephosphorylation
and activation of Src and Fyn [1–3]. We have generated
mice lacking catalytically active PTPα to address the
question of whether PTPα is a physiological activator of
Src and Fyn, and to investigate its other potential
functions in the context of the whole animal. Mice
homozygous for the targeted PTPα allele (PTPα –/–) and
lacking detectable PTPα protein exhibited no gross
phenotypic defects. The kinase activities of Src and Fyn
were significantly reduced in PTPα –/– mouse brain and
primary embryonic fibroblasts, and this correlated with
enhanced phosphorylation of the carboxy-terminal
regulatory Tyr527 of Src in PTPα –/– mice. Thus, PTPα is
a physiological positive regulator of the tyrosine kinases
Src and Fyn. Increased tyrosine phosphorylation of
several unidentified proteins was also apparent in
PTPα –/– mouse brain lysates. These may be PTPα
substrates or downstream signaling proteins. Taken
together, the results indicate that PTPα has a dual
function as a positive and negative regulator of tyrosine
phosphorylation events, increasing phosphotyrosyl
proteins through activation of Src and Fyn, and directly
or indirectly removing tyrosine phosphate from other
unidentified proteins. 
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Results and discussion
Mice with a targeted disruption of the PTPα allele
The targeting vector we used (Figure 1a) destroys the
junction between exon 13 and 14 — which forms the
active site of the first catalytic domain (D1) of PTPα
[4] — and disrupts the open reading frame of downstream
exons. Two PTPα-targeted embryonic stem (ES) cell
clones, both confirmed to have a single site of integration
(data not shown), were used to produce chimeric mice that
transmitted the modified PTPα allele to their offspring.
PCR (data not shown) and Southern blot analyses of tail
genomic DNA confirmed the transmission of the modified
PTPα allele(s) (Figure 1b). The PTPα +/– and PTPα –/–
mice were viable, fertile and without any observable
abnormalities up to 9 months of age. One line of mice was
used for the experiments detailed below. Some of these
experiments were also carried out with mice from the
other line, with similar results (see Supplementary mater-
ial published with this paper on the internet).
Figure 1
Targeted ablation of the PTPα gene. (a) A schematic representation of
the PTPα wild-type allele (top), targeting vector (middle) and the
modified allele (bottom). The targeting vector was made by replacing the
SphI–KpnI fragment with a NEO cassette, and an HSV thymidine kinase
(TK) gene was ligated to the 5′ end of the construct. P1 and P2 are
primers used in the initial ES cell colony screening. Positive clones were
later confirmed by Southern blotting of EcoRI-restricted genomic DNA
using probe A. E, EcoRI; K, KpnI; N, NheI; S, SphI; E11–E18 are exon
numbers. (b) NheI-digested genomic DNA from a PTPα-targeted ES cell
clone that produced a germline chimera, and from tail biopsies from
PTPα +/+, PTPα +/– and PTPα –/– mice, was hybridized with probe B.
Primers P3 and P4 were subsequently used to PCR-genotype the mice.
(c) Brain lysates (40 µg) were analysed for PTPα expression by western
blotting (top panel) and, as a loading control, for actin (bottom panel).
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PTPα is highly expressed in brain [5], and was readily
detected upon probing of brain lysates from wild-type
(PTPα +/+) animals. Much less PTPα was present in brain
lysates from PTPα +/– animals and no PTPα was detected
in brain lysates from PTPα –/– animals (Figure 1c), thus
correlating with the PTPα genotype. Whereas truncated
forms of PTPα may be produced, comprising parts of
PTPα prior to the targeted disruption in D1, we were
unable to detect such products using a polyclonal antibody
raised against recombinant D1 protein (data not shown).
Reduced Src/Fyn activities in PTPα mutant mice
Previous studies have indicated that ectopically over-
expressed PTPα dephosphorylates and activates Src and
Fyn [1–3]. To establish unequivocally whether PTPα is a
physiological regulator of these tyrosine kinases, we exam-
ined the activity of Src and Fyn immunoprecipitated from
brain lysates of PTPα +/+, PTPα +/– and PTPα –/– mice. The
PTPα –/– mice had significantly reduced brain Src activity,
which was 41% of the enolase kinase activity and 53% of
the autophosphorylation activity of PTPα +/+ mice
(Figure 2a,b). The PTPα +/– mice also displayed reduced
brain Src activity, with 45% of the enolase kinase activity
and 63% of the autophosphorylation activity of the wild-
type mice (Figure 2a,b). Compared to that of wild-type
mice, Fyn from PTPα –/– mouse brains displayed 29% and
36% of the wild-type enolase kinase and autophosphoryla-
tion activity, respectively, whereas Fyn from PTPα +/–
mouse brains had 65% and 57% of the wild-type Fyn
enolase kinase and autophosphorylation activity, respec-
tively (Figure 2c,d). On average, the lack of PTPα resulted
in Src and Fyn having only about 40% of the overall kinase
activity observed in wild-type mice. Csk, a negative regu-
lator of Src [6], had similar activity in brain lysates of mice
of all three genotypes (see Supplementary material).
The activities of Src and Fyn precipitated from primary
embryonic fibroblast cultures were also assayed. The
activity of Fyn was very low and difficult to measure reli-
ably. As in brain, the Src enolase kinase and autophospho-
rylation activities were reduced, being 31% and 28%,
respectively, in cells from PTPα –/– embryos, and 45% and
51%, respectively, in cells from PTPα +/– embryos, com-
pared to those in cells from PTPα +/+ embryos
(Figure 2e,f). As in brain, PTPα expression in cell lysates
correlated with PTPα genotype (data not shown).
Notably, Src and Fyn activities were reduced not only in
PTPα –/– mice, but also in PTPα +/– mice. Thus, in a wild-
type situation, even a partial inhibition of PTPα activity
may have functional consequences on Src and Fyn activi-
ties. Whether the reduced, but still detectable, Src and
Fyn activities in PTPα –/– mice represent basal kinase
activity in the absence of activation by PTPα, or a subpop-
ulation of Src/Fyn that is not regulated by PTPα, is
unknown. The latter seems likely, because Src activation
through non-phosphatase-dependent mechanisms, such as
Src homology 2 (SH2)-domain binding to the activated
platelet-derived-growth-factor receptor [7,8] can occur,
and because other PTPs besides PTPα can regulate Src
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Figure 2
Kinase activities of Src and Fyn from wild-type and PTPα-deficient
mice. Immunoprecipitated (a,b) Src or (c,d) Fyn from brain lysates of
litter-matched mice, and (e,f) Src immunoprecipitated from primary
fibroblast cultures of littermate mouse embryos, were assayed for kinase
activity and the amount of Src or Fyn protein determined by western
blotting. (a,c,e) Autophosphorylation of Src or Fyn (grey bars) or enolase
kinase activities (black bars), after equalization for Src or Fyn amounts.
Src or Fyn activities from PTPα +/+ mice were taken as 100%. (a) Bars
represent the mean activities of each lysate from two mice (PTPα +/+
and PTPα +/–), and the mean ± standard error from three mice
(PTPα –/–). Src activities from PTPα –/– and PTPα +/+ mice were
significantly different (autophosphorylation, p < 0.05; enolase kinase
activity, p < 0.01). (c) As in (a); Fyn activities from PTPα –/– and
PTPα +/+ mice were significantly different (autophosphorylation,
p < 0.01; enolase kinase activity, p < 0.05). (e) Bars represent the
averages of kinase activities from cells taken from two sets of embryos.
All PTPα genotypes were represented in each embryo set, and the Src
activity from PTPα +/+ fibroblasts was taken as 100% for that set. Src
activities from PTPα –/– and PTPα +/+ fibroblasts were significantly
different (autophosphorylation, p < 0.01; enolase kinase activity,
p < 0.02). (b,d,f) Representative autoradiographs from enolase kinase
assays of an experiment in (a,c,e), respectively (top panel), and the
corresponding immunoblot for Src or Fyn amounts (bottom panel).
Lane 1, PTPα +/+; lane 2, PTPα +/–; lane 3, PTPα –/–.
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and Fyn activities. For example, Src kinase activity is vir-
tually undetectable in unstimulated thymocytes of mice
deficient in the PTP SHP-1 [9] (indicating that a lower
level of kinase activity than that found in PTPα –/– brain
lysates is indeed possible). Regulation of Fyn by CD45 is
involved in T-cell receptor signaling [10]. Various phos-
phatase–Src (and Src family members) interactions may be
determined by cell type, subcellular localization, and
linkage to specific upstream effectors. Our results suggest
that about 60–70% of brain Src and Fyn or fibroblast Src is
primarily regulated by PTPα.
Enhanced Src Tyr527 phosphorylation in PTPα –/– mice 
Src activity is linked to its phosphorylation state, with
dephosphorylation of Tyr527 resulting in elevated kinase
activity [11,12]. Phosphopeptide mapping of Src from
32P-labeled PTPα +/+ and PTPα –/– fibroblasts showed a
31 kDa fragment corresponding to the serine/threonine-
phosphorylated amino terminus, and a 4 kDa carboxy-ter-
minal phosphopeptide containing the regulatory Tyr527
site (Figure 3a). The ratio of the 31 kDa to the 4 kDa
phosphopeptide was 4.5 for PTPα –/– fibroblast Src, about
fourfold lower than the ratio of 19 for PTPα +/+ fibroblast
Src. Assuming that serine/threonine phosphorylation of
the amino terminus of Src is not affected by PTPα, this
indicates that the absence of PTPα results in higher
phosphorylation of Tyr527.
An anti-Src antibody (Src2) that recognizes only the Tyr527-
dephosphorylated form of Src [9] was used to confirm the
above results. Brain lysates were precipitated with either
this antibody or with Ab-1, which recognizes Src indepen-
dent of its phosphorylation state (Figure 3b). Whereas
similar amounts of Src were precipitated by Ab-1 from
brains of all genotypes, less Src was precipitated by the Src2
antibody from PTPα –/– and PTPα +/– brains (about 42% and
47%, respectively) than from PTPα +/+ brains (Figure 3c).
Together with the phosphopeptide mapping, these results
indicate that reduced activity of Src in the PTPα –/– mice is
due to the absence of PTPα-mediated dephosphorylation
of the regulatory carboxy-terminal Tyr527.
Alterations in phosphotyrosyl proteins
Anti-phosphotyrosine immunoblotting revealed an elevated
phosphotyrosine content of proteins of about 175, 83 and
63 kDa in brain lysates from PTPα –/– mice compared to
PTPα +/+ or PTPα +/– mice (Figure 4). This suggests that
the tyrosine phosphorylation of these proteins is negatively
regulated by PTPα and that they may be novel PTPα sub-
strates or downstream components of PTPα-mediated
pathways, raising the possibility that certain signaling
events could involve negative regulators of PTPα activity.
Interestingly, the brain phosphotyrosyl protein profile of
PTPα +/– mice closely resembled that of PTPα +/+ mice, in
contrast to the PTPα +/– mice being similar to the PTPα –/–
mice in having reduced brain Src and Fyn activities. This
difference could reflect a requirement for different thresh-
old levels of PTPα activity to regulate the phosphorylation
status of different substrates and may be related to a possi-
ble dual function of PTPα as a positive and a negative regu-
lator of tyrosine phosphorylation events. In the positive
sense, and in the absence of inhibition, PTPα could acti-
vate the kinases Src and Fyn, with consequent tyrosine
phosphorylation of their downstream substrates. Inhibition
of PTPα would inhibit the Src kinase pathways and, if the
downregulation of PTPα is strong or prolonged, enhance
tyrosine phosphorylation of a different set of proteins.
Targeted disruption of PTPα has produced homozygous
mice lacking catalytically active PTPα. The constitutive
reduction in Src and Fyn activities, the concomitantly
enhanced tyrosine phosphorylation of the regulatory
carboxy-terminal site of Src, and the unaltered activity of
the Src kinase Csk observed in PTPα –/– mice, suggest
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Figure 3
Phosphorylation status of Src. (a) Phospho-
peptides from cyanogen-bromide cleavage of
in vivo labeled Src from primary fibroblasts of
littermate PTPα +/+ and PTPα –/– embryos. The
arbitrary densitometric units of the
phosphopeptides and the ratio of the 31 kDa to
the 4 kDa phosphopeptide are shown. (b) Src
was precipitated from brain lysates of littermate
mice with antibody Src2 (top panel) or Ab-1
(bottom panel), and probed with Ab-1.
(c) Amounts of Src precipitated with Ab-1
(shaded bars) or Src2 (black bars) were
determined from at least three independent
experiments, as in (b). The arbitrary
densitometric units of Src precipitated from
PTPα +/+ brains were taken as 100. Bars show
the mean ± standard deviation. Significant
differences are denoted by single (p < 0.05)
and double (p < 0.01) asterisks. 
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that PTPα is a Src/Fyn phosphatase. Furthermore, these
results demonstrate that PTPα is a positive physiological
regulator of these Src family tyrosine kinases. The lack of
gross phenotypic abnormalities of the mutant animals
suggests that the catalytic function of PTPα is not essen-
tial for embryonic development, or perhaps reflects the
potential expression and correct localization of truncated
extracellular forms of PTPα which can fulfill an
unknown normal function(s) as a ligand. Alternatively,
this observation could reflect the reduced but residual
Src/Fyn activities. Studies of Src- and Fyn-deficient mice
indicate that Src is not required for general cell viability
[13] and that Fyn is not required for general growth and
differentiation [14]. Specialized and overlapping pheno-
types of these mice or alterations in cells derived from
them have since been described [15], and further exami-
nation of the PTPα –/– mice will determine whether a
lack of PTPα-activated Src or Fyn gives rise to similar, or
to other specialized or restricted, differences which are
not grossly apparent.
Materials and methods
Generation of PTPα-deficient mice
PTPα genomic clones were isolated from a 129Sv genomic DNA
library in Lambda DASH II (a gift from P. Stambrook). The targeting
vector was constructed from a 7 kb EcoRI fragment isolated from one
of the clones, and had a neo gene flanked by 2 kb of 5′ homology and
4.5 kb of 3′ homology (Figure 1a). An HSV thymidine kinase gene (a
gift from L. Kranias) was cloned upstream of the 5′ homology region as
a negative selection marker. ES cells (RW4, Genome Systems) were
electroporated with the targeting vector and subjected to G418 and
ganciclovir selection. Resistant colonies were analyzed by PCR using
primers P1 and P2 and positive clones confirmed by Southern blotting
using probe A (Figure 1a) and the neo probe. The PTPα-targeted
clones were injected into C57Bl/6 blastocysts to generate chimeric
mice. Male germline chimeras were mated to Blk Swiss mice to
produce mice heterozygous for the PTPα allele, and these were mated
to generate mice lacking PTPα. Primary fibroblasts were prepared from
day 14 embryos of matings of PTPα heterozygotes. Yolk sac or embry-
onic liver DNA was used for PCR genotyping.
Immunoprecipitation, western blotting and kinase assays
Whole brains or primary embryonic fibroblast cultures (passages 3 and
4) were lysed in modified RIPA buffer [3]. Immunoprecipitates were
prepared from lysates (0.5–0.8 mg protein) using either anti-Src (Ab-1,
Oncogene Science, or Src2, Santa Cruz), or anti-Fyn (FYN3-G, Santa
Cruz) antibodies. Anti-PTPα-D1 antiserum 2205, anti-Src, anti-Fyn,
anti-actin (Sigma A2066) or anti-phosphotyrosine PY20 (Transduction
Laboratories) antibodies were used for immunoblotting. Src and Fyn
immunoprecipitates were assayed for kinase activity, and Src phospho-
peptide mapping was carried out essentially as described [1].
Supplementary material
Supplementary figures showing the Csk and Src activities of PTPα
mutant mice and additional methodological details are published with
this paper on the internet. 
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Figure 4
Phosphotyrosyl protein profiles in wild-type and PTPα-deficient mice.
(a) Brain lysates from littermate PTPα +/+, PTPα +/–, and two PTPα –/–
mice were probed with anti-phosphotyrosine antibody. (b) The same
membrane as in (a), except with longer signal detection to show up the
83 kDa band. (c) Equal loading of the lanes was confirmed by
reprobing the membrane for actin.
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Supplementary results and discussion
Csk activity is not affected in PTPα mutant mice
The tyrosine kinase Csk is a key negative regulator of Src,
phosphorylating Tyr527 to maintain Src in an inhibited
state [S1,S2]. Although PTPα could indirectly activate Src
by direct or indirect inhibition of Csk, no alterations in
Csk protein levels were detected by immunoblotting of
PTPα+/+, PTPα+/–, and PTPα–/– brain lysates, and Csk
immunoprecipitates showed no differences in in vitro
kinase activity.
Supplementary materials and methods
The Csk immunoprecipitates (antibody C-20, Santa Cruz) were
assayed in reactions containing 50 mM Tris pH 7.4, 3 mM MnCl2,
0.1 mM Na3VO4, 0.1 mM [γ-32P]ATP and 1.4 mM RR-Src peptide
(RRLIEDAEYAARG). After 30 min at 30°C, the Csk reactions were
spotted onto P81 phosphocellulose papers which were washed and
quantitated for radioactivity. The counts per minute (cpm) of reactions
containing control immunoprecipitates prepared without anti-Csk anti-
body were taken as background and subtracted from those of reac-
tions containing the Csk immunoprecipitates. As a positive control,
recombinant Csk was also assayed and found to have excellent kinase
activity towards this peptide substrate (data not shown).
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Supplementary material
Figure S1
Kinase activity of Csk from wild-type and PTPα-deficient mice.
(a) Brain lysates from PTPα+/+ (+/+), PTPα+/– (+/–), and PTPα–/–
(–/–) mice were probed for Csk expression. (b) Csk
immunoprecipitates from the lysates were assayed for kinase activity in
vitro. The activity from PTPα+/+ brain was taken as 100%. Bars
represent the mean ± standard deviation.
50
100
Csk
+/+ +/– –/–
+/+ +/– –/–
 A
ct
iv
ity
 (%
)
(a) (b)
Current Biology
Figure S2
Brain Src activity and Tyr527 phosphorylation are similarly affected in
PTPα-deficient mice produced from another ES cell clone. Mice
descended from a germline chimera derived from a different PTPα-
targeted ES cell clone were used in the following experiments.
(a) Enolase kinase activities of Src immunoprecipitated from PTPα+/+,
PTPα+/– and PTPα–/– mouse brain lysates after equalization for Src
amounts. Methods are as described in Figure 2a. (b) The amount
(units) of Tyr527-dephosphorylated Src, as determined by the ratios of
the amount of Src precipitated with the antibody Src2 to the amount
precipitated with antibody Ab-1. Methods are as in Figure 3b. The
amounts of Src immunoprecipitated from PTPα+/+ mice with Ab-1 and
with Src2 were taken as 100 densitometric units, and the amounts
immunoprecipitated from brain lysates of mice of the other genotypes
was taken relative to these for the appropriate antibody.
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